References
- Binder M., Agurell S., Leander K., Lindgren J.-E. Zur Identifikation potentieller Metabolite von Cannabis-Inhaltsroffen: Kernresonanz und massenspektropische Untersuchungen an seitenkettenhydroxylierten Cannabinoiden. Helvetica Chimica Acta 1974; 57: 1626–1641
- Brown N. K., Harvey D. J. Metabolism and potency of tetrahydrocannabinol homologues. British Journal of Pharmacology 1987; 92: 724P
- Brown N. K., Harvey D. J. In vivo metabolism of the n-propyl homologues of delta-8- and delta-9-tetrahydrocannabinol in the mouse. Biomedical and Environmental Mass Spectrometry 1988; 15: 403–410
- Consroe P., Snider S. R. Therapeutic potential of cannabinoids in neurological disorders. Cannabinoids as Therapeutic Agents, R. Mechoulam. CRC Press, Boca Raton, FL 1986; 21–49
- Consroe P., Martin A., Mechoulam R. Anticonvulsant effects of cannabidiol stereoisomers and analogs in rats. Marihuana '84: Proceedings of the Oxford Symposium on Cannabis, D. J. Harvey. IRL Press, Oxford 1985; 705–712
- Harvey D. J. The mass spectra of the trimethylsilyl derivatives of the hydroxy and acid metabolites of delta-1- and delta-6-tetrahydrocannabinol. Biomedical Mass Spectrometry 1981; 8: 579–588
- Harvey D. J. Identification of hepatic metabolites of n-heptyl-delta-1-tetrahydrocannabinol in the mouse. Xenobiotica 1985; 15: 187–197
- Harvey D. J. Mass spectrometry of the cannabinoids and their metabolites. Mass Spectrometry Reviews 1987; 6: 135–229
- Harvey D. J. Further studies on the oxidative cleavage of the pentyl side-chain of cannabinoids: identification of new biotransformation pathways in the metabolism of 3′-hydroxy-delta-9-tetrahydrocannabinol by the mouse. Xenobiotica 1989; 19(12)1437–1447
- Harvey D. J., Mechoulam R. Metabolites of cannabidiol identified in human urine. Xenobiotica 1990; 20(3)303–320
- Harvey D. J., Martin B. R., Paton W. D. M. Identification of di- and tri-substituted hydroxy and ketone metabolites of delta-1-tetrahydrocannabinol in mouse liver. Journal of Pharmacy and Pharmacology 1977; 29: 482–486
- Martin B., Nordqvist M., Agurell S., Lindgren J.-E., Leander K., Binder M. Identification of monohydroxylated metabolites of cannabidiol formed by a rat liver. Journal of Pharmacy and Pharmacology 1976; 28: 275–279
- Martin B., Agurell S., Nordqvist M., Lindgren J.-E. Dioxygenated metabolites of cannabidiol formed by rat liver. Journal of Pharmacy and Pharmacology 1976 b; 28: 603–608
- Martin B. R., Harvey D. J., Paton W. D. M. Biotransformation of cannabidiol in mice: identification of new acid metabolites. Drug Metabolism and Disposition 1977; 5: 259–267
- McCloskey J. A., Stillwell R. N., Lawson A. M. Use of deuterium labelled trimethylsilyl derivatives in mass spectrometry. Analytical Chemistry 1968; 40: 233–236
- Mechoulam R., Lander N., Srebnik M., Breuer A., Segal M., Feigenbaum J. J., Jarbe T. U. C., Consroe P. Stereochemical requirements for cannabimimetic activity. NIDA Research Monograph Series 1987; 79: 15–30
- Meijer D. F. K., Keulemans K., Mulder G. J. Isolated perfused rat liver technique. Methods in Enzymology 1981; 77: 81–94
- Razdan R. K. Structure-activity relationships in cannabinoids. Pharmacological Reviews 1986; 38: 75–149
- Samara E., Bialer M. Pharmacokinetics of the dimethylheptyl homolog of cannabidiol in dogs. Drug Metabolism and Disposition 1988; 16: 875–878
- Samara E., Brown N. K., Harvey D. J. Microsomal metabolism of the 1′,1′-dimethylheptyl analogue of cannabidiol. Drug Metabolism and Disposition 1990a, (in press)
- Samara E., Bialer M., Harvey D. J. Identification of cannabidiol metabolites in the rat. Drug Metabolism and Disposition 1990b, (in press)
- Samara E., Bialer M., Harvey D. J. Identification of urinary metabolites of cannabidiol in the dog. Drug Metabolism and Disposition 1990 c, (in press)
- Turner C. E., ElSohly M. A., Boeren E. G. Constituents of Cannabis sativa L. XVIII. A review of the natural constituents. Journal of Natural Products 1980; 43: 169–234